乳腺癌 - 医索

找到约 32963 条结果

Enfortumab Vedotin in the HR HER2-and Triple-Negative Breast CancerCohorts of EV-202 - 副本

医客学院 - 会议报告集

Elucidating the lmmune Active State of HR HER2.MammaPrint High 2 Early Breast Cancer

医客学院 - 会议报告集

ECOG-ACRIN EAZ171 Prospective validation trial of germline variants and taxane type in association with taxane-induced peripheral neuropathy (TlPN) in Black women with early-stage breast cancer

医客学院 - 会议报告集

Development and validation of RsclinN toolfor hormone receptor-positive(HR ),HER2-negative(HER2-)node-positive breast cancer

医客学院 - 会议报告集

DESTINY-Breast07dose-expansion analysis ofT-DXd monotherapy and T-DXd pertuzumab inpatients with previously untreated HER2 mBC

医客学院 - 会议报告集

Datopotamab deruxtecan (Dato-DXd)vs chemotherapy inpreviously-treated inoperable or metastatic hormonereceptor-positive, HER2-negative (HR HER2-) breast cancerPatient-reported outcomes(PROs) from

医客学院 - 会议报告集

Comparison antitumor efficacy Of first-line Of Palbociclib, Ribociclib or Abemaciclib in patients with HR HER2-aBC results of the multicenter, real-world,Italian study PALMARES-2

医客学院 - 会议报告集

Cognitive function in women with HR advanced breast cancer treated withendocrine therapy ± CDK46 inhibitors

医客学院 - 会议报告集

Clinical utility of molecular imagingin newly diagnosed metastatic breastcancerIMPACT-MBC study

医客学院 - 会议报告集

Baseline characteristics and efficacyendpoints for patients with node-negativeHR HER2-early breast cancer in NATALEE

医客学院 - 会议报告集

今日实时热搜